Skip to content
Menu

Bicycle Therapeutics Q3 EPS $(0.15) Beats $(0.48) Estimate, Sales $34.057M Beat $6.069M Estimate

Benzinga Newsdesk 3 weeks ago

NewsEarningsEarnings Beats

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.48) by 68.75 percent. This is a 82.35 percent increase over losses of $(0.85) per share

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.48) by 68.75 percent. This is a 82.35 percent increase over losses of $(0.85) per share from the same period last year. The company reported quarterly sales of $34.057 million which beat the analyst consensus estimate of $6.069 million by 461.14 percent. This is a 190.24 percent increase over sales of $11.734 million the same period last year.

Read at benzinga.com

← All stock news